Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trial.
Gastroenterology, CHU Le Bocage, Burgundy University, INSERM U866, Dijon, France; FFCD, Burgundy University, INSERM U866, Dijon, France. Electronic address: Come.Lepage@U-Bourgogne.Fr.
Côme
C
Lepage
Gastroenterology, CHU St Etienne, France.
Jean-Marc
JM
Phelip
Gastroenterology, CHG Perigueux, France.
Laurent
L
Cany
Gastroenterology, CHG La Roche sur Yon, France.
Roger
R
Faroux
Gastroenterology, CHU Rennes, France.
Sylvain
S
Manfredi
Gastroenterology, Private Hospital, Val de Saône, Macon, France.
Jean-Francois
JF
Ain
Digestive Surgery, CHU Clermont Ferrand, France.
Denis
D
Pezet
Gastroenterology, CHG Annecy, France.
Mathieu
M
Baconnier
Gastroenterology, CHG St Nazaire, France.
Philippe
P
Deguiral
Gastroenterology, CH Pessac, France.
Eric
E
Terrebone
Medical Oncology, Oscar Lambret Center, Lille, France.
Antoine
A
Adenis
FFCD, Burgundy University, INSERM U866, Dijon, France.
Karine
K
Le Malicot
Gastroenterology, CHU Le Bocage, Burgundy University, INSERM U866, Dijon, France; FFCD, Burgundy University, INSERM U866, Dijon, France.
Laurent
L
Bedenne
Gastroenterology, CHU Reims, France.
Olivier
O
Bouché
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002272:Carcinoembryonic Antigen / Q000097:blood*; D002985:Clinical Protocols; D015179:Colorectal Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000401:mortality / Q000601:surgery; D055088:Early Detection of Cancer / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D057194:Intention to Treat Analysis; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000175:diagnosis* / Q000401:mortality; D011446:Prospective Studies; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
D002272:Carcinoembryonic Antigen